Analyst Undervalued Stocks on the NYS November 2024

November 04, 2024

Analyst Undervalued

Companies on this list are considered undervalued based on the analyst consensus. This means that the average analyst target price is greater than the close price.

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

About the Data

This table includes the close price and analyst target price mean from most recent available data. The fiscal year indicates the year for the analyst target price, as the target may not always be for the current year. The number of estimates indicates the number of analyst targets used to calculate the target price mean.

How do you use this table?

Analysts believe that the companies on this list will see the close price move up to their target price mean by the target year indicated. Companies with a large analyst following or large difference between close price and target price are particularly interesting to investigate further. This becomes a starting point for further analysis to understand why these companies are undervalued. Stocks in this category are generally held for capital appreciation or dividends.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose PriceTarget Price MeanTarget YearNumber of EstimatesCurrency
BRK.A Berkshire Hathaway Inc 678000.00 751862.00 2025 2 USD
LLY Eli Lilly and Co 818.93 1016.67 2025 3 USD
TMO Thermo Fisher Scientific Inc 557.92 679.33 2025 3 USD
NOW ServiceNow Inc 943.41 1022.57 2025 7 USD
SPGI S&P Global Inc 483.31 598.33 2025 3 USD
ELV Elevance Health Inc 414.01 516.50 2025 2 USD
SHW Sherwin-Williams Co 357.97 451.50 2025 2 USD
CI The Cigna Group 316.49 401.25 2025 4 USD
TDG TransDigm Group Inc 1304.50 1491.00 2025 2 USD
FICO Fair Isaac Corp 1988.91 2083.00 2025 3 USD
All data provided as at market close October 31, 2024.

Company Details

Berkshire Hathaway Inc

BRK.A:NYS

Close Price

678000.00

Target Price Mean

751862.00

Target Year

2025

Target Price # Estimates

2

Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group.

Access the stockcalc valuation


Eli Lilly and Co

LLY:NYS

Close Price

818.93

Target Price Mean

1016.67

Target Year

2025

Target Price # Estimates

3

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Access the stockcalc valuation


Thermo Fisher Scientific Inc

TMO:NYS

Close Price

557.92

Target Price Mean

679.33

Target Year

2025

Target Price # Estimates

3

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).

Access the stockcalc valuation


ServiceNow Inc

NOW:NYS

Close Price

943.41

Target Price Mean

1022.57

Target Year

2025

Target Price # Estimates

7

ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

S&P Global Inc

SPGI:NYS

Close Price

483.31

Target Price Mean

598.33

Target Year

2025

Target Price # Estimates

3

S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry.

Access the stockcalc valuation


Elevance Health Inc

ELV:NYS

Close Price

414.01

Target Price Mean

516.50

Target Year

2025

Target Price # Estimates

2

Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states.

Access the stockcalc valuation


Sherwin-Williams Co

SHW:NYS

Close Price

357.97

Target Price Mean

451.50

Target Year

2025

Target Price # Estimates

2

Sherwin-Williams is the largest provider of architectural paint in the United States. The company has over 5,000 stores and sells premium paint at higher price points than most competitors. Sherwin-Williams also sells paint-related products in big-box stores and provides coatings for original equipment manufacturers.

Access the stockcalc valuation


The Cigna Group

CI:NYS

Close Price

316.49

Target Price Mean

401.25

Target Year

2025

Target Price # Estimates

4

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene.

Access the stockcalc valuation


TransDigm Group Inc

TDG:NYS

Close Price

1304.50

Target Price Mean

1491.00

Target Year

2025

Target Price # Estimates

2

TransDigm manufactures and services a diverse set of specialized parts for commercial and military aircraft. The firm organizes itself in three segments: power and control, airframes, and a small non-aviation segment, which serves mostly off-road vehicles and mining equipment. It operates as an acquisitive holding company that focuses its portfolio on firms that make proprietary aerospace products with substantial aftermarket demand.

Access the stockcalc valuation


Fair Isaac Corp

FICO:NYS

Close Price

1988.91

Target Price Mean

2083.00

Target Year

2025

Target Price # Estimates

3

Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Berkshire Hathaway and Eli Lilly are among the most undervalued NYS stocks this month. See the most undervalued companies on the blog: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nys-november-2024
Berkshire Hathaway $BRK.A and Eli Lilly $LLY on the #NYS among the most undervalued this month. See the full list of undervalued companies: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nys-november-2024
Berkshire Hathaway and Eli Lilly are among the most undervalued NYS stocks this month. See the most undervalued companies on the blog: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nys-november-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.